Biobanking Market - Application, Product and Service Biobanking | Page 3

Rising incidence of blood disorders and the increasing demand for various types of blood
products across the globe are driving the growth of this segment.
Browse and in-depth TOC on "Biobanking Market"
123 - Tables
64 - Figures
164 - Pages
View more detailed TOC @
https://www.marketsandmarkets.com/Market-Reports/biobanking-devices-market-594.html
North America is expected to account for the largest share of the market in 2017
Based on region, the Biobanking Market is segmented into North America, Europe, Asia-Pacific,
and Rest of the World (RoW). North America is expected to dominate the Biobanking Market in
2017, this is attributed to factors like increasing research activities in regenerative medicine, cell
and gene therapy; growing interest in personalized medicine and biomarker discovery; increasing
number of biotechnology and pharmaceutical companies; and rising investments in genomics
and proteomics research in the region as compared to other regions.
Request for Free Sample Report @
https://www.marketsandmarkets.com/requestsample.asp?id=594
Key players in the Biobanking Market include Thermo Fisher Scientific Inc. (U.S.), Tecan Group
Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.),
TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington
Industries [(Taylor Wharton, U.S.)], Chart Industries (U.S.), Becton, Dickinson and Company
(U.S.), Merck KGaA (Germany), Micronic (Netherlands), LVL Technologies GmbH & Co. KG
(Germany), Panasonic Healthcare Holdings Co. Ltd (Japan), Greiner Bio One [Greiner Holding
AG, Austria)], Biokryo GmbH (Germany), Biobank AS (Norway), Biorep Technologies Inc. (U.S.),
Cell & Co Bioservices (France), RUCDR infinite biologics (U.S.), Modul-Bio (France), CSols Ltd
(U.K.), Ziath (U.K.), and LabVantage Solutions Inc. (U.S.).
Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting